Eisai Revenue vs. Current Valuation
| ESALF Stock | USD 28.50 0.02 0.07% |
For Eisai profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eisai to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eisai Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eisai's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eisai Co over time as well as its relative position and ranking within its peers.
Eisai |
Eisai Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Eisai's current stock value. Our valuation model uses many indicators to compare Eisai value to that of its competitors to determine the firm's financial worth. Eisai Co is rated # 2 in revenue category among its peers. It is rated as one of the top companies in current valuation category among its peers reporting about 0.02 of Current Valuation per Revenue. The ratio of Revenue to Current Valuation for Eisai Co is roughly 40.22 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eisai's earnings, one of the primary drivers of an investment's value.Eisai Revenue vs. Competition
Eisai Co is rated # 2 in revenue category among its peers. Market size based on revenue of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 1.51 Trillion. Eisai totals roughly 756.23 Billion in revenue claiming about 50% of equities under Drug Manufacturers—Specialty & Generic industry.
Eisai Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Eisai |
| = | 756.23 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Eisai |
| = | 18.8 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Eisai Current Valuation vs Competition
Eisai Co is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 18.91 Billion. Eisai totals roughly 18.8 Billion in current valuation claiming about 99% of equities under Drug Manufacturers—Specialty & Generic industry.
Eisai Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Eisai, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eisai will eventually generate negative long term returns. The profitability progress is the general direction of Eisai's change in net profit over the period of time. It can combine multiple indicators of Eisai, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
It offers Aricept for the treatment of alzheimers diseasedementia with Lewy bodies Methycobal for the treatment of peripheral neuropathy and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan. Eisai operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 11322 people.
Eisai Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Eisai. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eisai position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eisai's important profitability drivers and their relationship over time.
Use Eisai in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eisai position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eisai will appreciate offsetting losses from the drop in the long position's value.Eisai Pair Trading
Eisai Co Pair Trading Analysis
The ability to find closely correlated positions to Eisai could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eisai when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eisai - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eisai Co to buy it.
The correlation of Eisai is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eisai moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eisai moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eisai can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Eisai position
In addition to having Eisai in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Picks Thematic Idea Now
Macroaxis Picks
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Eisai Pink Sheet
To fully project Eisai's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Eisai at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Eisai's income statement, its balance sheet, and the statement of cash flows.